tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Li Watsek, 115 are a BUY (96.64%), 4 are a HOLD (3.36%).
Analyst Li Watsek, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 39.17% that have a potential upside of 43.98% achieved within 203 days. Previously, Li Watsek worked at BAML.
Li Watsek’s has documented 203 price targets and ratings displayed on 20 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASND, Ascendis Pharma AS at 01-Apr-2026.
Analyst best performing recommendations are on FATE (FATE THERAPEUTICS).
The best stock recommendation documented was for FATE (FATE THERAPEUTICS) at 5/4/2023. The price target of $5 was fulfilled within 8 days with a profit of $1.17 (18.96%) receiving and performance score of 23.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Aug-2023
$33
$19.51 (144.63%)
$32
7 months 15 days ago
(13-Mar-2026)
8/10 (80%)
$17.68 (115.40%)
314
Buy Since 02-Dec-2021
$42
$28.51 (211.34%)
$13
9 months 6 days ago
(22-Jan-2026)
2/3 (66.67%)
$16.48 (64.58%)
746
Buy Since 13-Oct-2025
$28
$17.47 (165.91%)
$16
9 months 7 days ago
(21-Jan-2026)
1/2 (50%)
$5.85 (26.41%)
99
Buy Since 02-Jan-2025
$27
$13.51 (100.15%)
$11
9 months 8 days ago
(20-Jan-2026)
3/4 (75%)
$5.59 (26.11%)
352
Buy Since 20-May-2025
$20
$9.47 (89.93%)
$13
9 months 8 days ago
(20-Jan-2026)
7/7 (100%)
$-1.41 (-6.59%)
195
What Year was the first public recommendation made by Li Watsek?
